A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against henipavirus – a genus (or group) of viruses including Nipah virus.
Novel semi-synthetic compound shows promise against drug-resistant tuberculosis
A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds